Beta-glucans (β-glucans), polysaccharides found in cereals and fungi, are recognized for their prebiotic and potential anti-cancer activities, particularly in the colorectal area. This study aims to optimize the production of β-glucan through the solid-state fermentation of germinated Riceberry rice with Pleurotus ostreatus and evaluate the bioactivities of the resulting extract. The crude β-glucan extract, obtained with a recovery rate of 54.95% and 79.98% purity, demonstrated an effective extraction process, as confirmed by thermogravimetric analysis (TGA). Fourier-transform infrared spectroscopy (FTIR) analysis verified the presence of β-1,3/1,6-glycosidic linkages, characteristic of the bioactive β-glucans found in yeast and mushrooms. The biological assessment demonstrated the extract’s functional properties. At a concentration of 1 mg/mL, the crude β-glucan extract significantly promoted the growth of probiotics Lacticaseibacillus rhamnosus and Bacillus coagulans, exhibiting high Prebiotic Index (PI) values of 6.36 ± 0.72 and 115.70 ± 10.19, respectively, with PI values indicating strong prebiotic potential. For comparison, the standard prebiotic inulin yielded PI values of 0.41 ± 0.09 and 90.53 ± 2.28 for the same respective bacteria, highlighting the superior performance of the fungal-fermented β-glucan. Furthermore, the extract displayed efficacy in inhibiting colon cancer cells in preliminary in vitro tests. It reduced the viability of the SW480 colorectal cancer cell line by 66.23% and induced cell death in 27.94 ± 0.93% of the cells after 48 h of treatment, performing comparably to a commercial yeast β-glucan standard. Crucially, the extract showed no significant cytotoxicity toward the normal human colon cell line, CCD-841 CoN. These findings highlight the promising method of fungal solid-state fermentation on germinated Riceberry rice in the production of high-purity, bioactive β-glucans for use in functional foods.
Cancer is a deadly disease that has claimed millions of lives worldwide. Traditional cancer treatments, such as chemotherapy and radiation, have been used for many years but have become less favored due to drug resistance, lack of tumor selectivity, high costs, and various side effects, such as fatigue and hair loss. Many studies have reported that animal venoms, such as those from snakes, scorpions, and bees, contain bioactive peptides that can be synthesized into anti-- cancer peptides (ACPs), which offer a potential alternative to traditional cancer therapies. Apitherapy is an area of growing interest for the development of new cancer treatments using bee venom, which is a complex mixture of biologically active peptides, enzymes, bioactive amines, and nonpeptide components that have been found to have anti-cancer properties. By leveraging these bioactive peptides, researchers could develop ACPs that are more targeted towards cancer cells, reducing the risk of adverse side effects and improving patient outcomes. The use of bee venom components in targeting cancer could provide a more selective, effective, and affordable approach to cancer therapy. While further research is needed, the potential benefits of using bee venom components in cancer therapy are significant and could help improve the lives of cancer patients worldwide. This study aims to review the components of bee venom as potential cancer treatments.
Streptococcus thermophilus is a thermophilic lactic acid bacterium that is commonly used in food fermentation. However, quantifying bacterial populations using conventional culture-dependent assays is laborious. The genome-based method has been recognized as an alternative rapid method. In this study, we developed a method to use a specific gene of S. thermophilus, the glucokinase gene (GlcK), by quantitative PCR (qPCR). A 139-bp PCR product was successfully cloned and used to generate a DNA standard curve by plotting the threshold cycle (Cq) versus log DNA concentration of plasmid DNA, with an amplification efficiency of 97.2%. Coefficient of variation was calculated by considering both Cq and bacterial cells enumerated by plate counts, which indicated a log CFU/mL (1.69-6.56) and log DNA copies (2.07-6.03). This linear relationship revealed a quantitative curve (R2 = 0.989) with a detection limit of range from 2.07 to 6.03 log copies per reaction. In terms of efficiency and repeatability, the relative standard deviations (RSDs) were in the range of 92-110% and 0.01%, respectively. Lastly, we used the developed qPCR method to determine the growth curves of bacterial cells and the specific growth rate (m) during batch culture for 24 h. The established method facilitated the determination of specific growth rates, showing a specific growth rate of 0.57 h-1 with lactose supplementation and 0.30 h-1 in the absence of lactose. Hence, qPCR-based methods facilitated reliable quantification of S. thermophilus during fermentation.
30 October 2026 in Journal of Agriculture and Food Research